CD47 and colorectal cancer: Dong [42] found that hyperoside degrades c-Myc (a flavonoid), down-regulating the expression of immune checkpoints PD-L1 and CD47, in addition to reshaping the MC38 colorectal cancer immune microenvironment in vivo to induce anti-colorectal cancer effects.